Use of nmda antagonists for treatment of irritable bowel...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/165 (2006.01) A61K 31/13 (2006.01) A61K 31/137 (2006.01) A61K 31/41 (2006.01) A61K 31/44 (2006.01) A61K 31/4402 (2006.01) A61K 31/495 (2006.01) A61K 31/4965 (2006.01)

Patent

CA 2329328

The invention relates to the use of pharmaceutical compounds having NMDA antagonist activity for treating certain conditions in the gastrointestinal tract, such as functional gastrointestinal disorders, and in particular irritable bowel syndrome (IBS). The invention also relates to pharmaceutical compositions to be used in the treatment of IBS and product comprising such compounds and a pharmaceutical acceptable carrier.

L'invention concerne l'utilisation de composés pharmaceutiques ayant une activité antagoniste de N-méthyle-D-aspartate (NMDA) pour traiter certains états du tractus gastro-instestinal, tels que des troubles fonctionnels gastro-intestinaux, et en particulier le syndrome du côlon irritable. L'invention concerne également des compositions pharmaceutiques à utiliser dans le traitement du syndrome du côlon irritable et un produit contenant de tels composés et un excipient pharmaceutiquement acceptable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of nmda antagonists for treatment of irritable bowel... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of nmda antagonists for treatment of irritable bowel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nmda antagonists for treatment of irritable bowel... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1646804

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.